Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea
about
Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory ConditionRosacea: a Clinical ReviewTopical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea TreatmentsImproving Treatment of Erythematotelangiectatic Rosacea with Laser and/or Topical Therapy Through Enhanced Discrimination of its Clinical FeaturesMajor pathophysiological correlations of rosacea: a complete clinical appraisalAcne and Rosacea.New insights into the antimicrobial effect of mast cells against Enterococcus faecalisIntegrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics.Skin microbiome and mast cells.A Role for Human Skin Mast Cells in Dengue Virus Infection and Systemic Spread.Ilomastat, a synthetic inhibitor of MMPs, prevents lung injury induced by γ-ray irradiation in mice.Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel.Rosacea, the face of innate immunity.The relationship between migraine and rosacea: Systematic review and meta-analysis.Inhibition of mast cell infiltration in an LL-37-induced rosacea mouse model using topical brimonidine tartrate 0.33% gel.Rosacea: Epidemiology, pathogenesis, and treatment.Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds.Skin neurogenic inflammation.The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury.
P2860
Q28067747-62A174E9-5EE0-48EF-9A94-459645E24128Q28069553-4FEC2348-DD56-4EA1-89AB-CD207FE6D29BQ28072685-28C77291-1A08-4396-8D21-F38393B300D6Q28077479-66958CAB-981F-4359-AFFB-F0820E0A57C6Q28082171-374A6009-587B-4E25-BDC7-6235F2718D7FQ30238647-E70FBE8E-5606-4549-870A-5C19E1DF1AEFQ34596183-6F2CFEF8-AC03-4F70-9C96-89E131FDE4A9Q38885566-8397AF40-4F31-4FE0-97C0-27FD6573C38DQ39228868-B6138045-4A67-44F0-8D53-1AE015B8EEE1Q40082082-97E85869-03A7-4D85-8CBC-E4FEC8221681Q42365246-9233FC29-E517-4F06-BC09-6B43DDB556FCQ45153684-F38975DD-E93F-4363-85B9-2D410E899123Q46464886-02D8C708-D04D-49B9-AD1F-9315AE3BAAE8Q47944255-9B840D5C-AA5A-4F09-AA9E-B692E6ABC2AFQ48149180-6E3FFAF9-40CC-42AF-AD77-27D8B67593F0Q50324762-A474A4E2-6856-4A69-8658-42F6B80CC0E0Q52592947-4542E8AA-778C-4059-9E79-87EEBE8AA4D4Q54224167-0BD1EE9E-F619-4E10-AA6E-0887684F27FCQ55104920-817AC2C1-2AB3-4847-8847-A790E080F2F1
P2860
Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea
@ast
Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea
@en
Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea
@nl
type
label
Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea
@ast
Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea
@en
Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea
@nl
prefLabel
Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea
@ast
Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea
@en
Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea
@nl
P2093
P2860
P50
P356
P1476
Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea
@en
P2093
Matthieu Vanderberghe
Yumiko Muto
P2860
P2888
P304
P356
10.1038/JID.2014.222
P407
P577
2014-05-20T00:00:00Z
P5875
P6179
1052831536